Rockefeller Financial Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$123M Buy
1,246,696
+1,246,528
+741,981% +$118M 1.94% 12
2017
Q3
$16K Sell
168
-3,158
-95% -$335K ﹤0.01% 488
2017
Q2
$370K Hold
3,326
0.01% 251
2017
Q1
$326K Sell
3,326
-265
-7% -$25.3K 0.01% 268
2016
Q4
$330K Hold
3,591
0.01% 282
2016
Q3
$304K Sell
3,591
-446
-11% -$37.5K 0.01% 282
2016
Q2
$329K Hold
4,037
0.01% 290
2016
Q1
$288K Sell
4,037
-110
-3% -$7.38K 0.01% 296
2015
Q4
$295K Hold
4,147
0.01% 306
2015
Q3
$255K Hold
4,147
0.01% 308
2015
Q2
$301K Hold
4,147
0.01% 277
2015
Q1
$319K Buy
+4,147
New +$297K 0.01% 282
2014
Q4
Sell
-4,147
Closed -$251K 490
2014
Q3
$251K Sell
4,147
-5,212
-56% -$321K 0.01% 312
2014
Q2
$549K Sell
9,359
-14,620
-61% -$856K 0.01% 255
2014
Q1
$1.39M Buy
23,979
+3,205
+15% +$172K 0.03% 204
2013
Q4
$1.11M Sell
20,774
-1,080
-5% -$64.1K 0.02% 225
2013
Q3
$1.35M Sell
21,854
-1,374
-6% -$82.2K 0.03% 211
2013
Q2
$1.41M Buy
+23,228
New +$1.38M 0.03% 202

Other funds holding DGX

Rockefeller Financial Services's DGX Position: Q4 2017 in Review

Rockefeller Financial Services increased its Quest Diagnostics (DGX) stake by 741,981% in Q4 2017, buying an estimated $118M and bringing the position to 1,246,696 shares worth $123M. The position accounts for 1.94% of the portfolio, ranked #12.

Rockefeller Financial Services first reported a position in DGX in Q2 2013 and has held it in 18 quarters since. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

  • Rockefeller Financial Services held 1,246,696 shares of Quest Diagnostics worth $123M as of Q4 2017.
  • Rockefeller Financial Services bought 1,246,528 Quest Diagnostics shares in Q4 2017, an estimated $118M.
  • Quest Diagnostics made up 1.94% of Rockefeller Financial Services's portfolio in Q4 2017, its #12 holding.
  • Rockefeller Financial Services first reported a position in Quest Diagnostics in Q2 2013 and has held it in 18 quarters since.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.